Article: GLP-1 After 40

GLP-1 After 40
Why Perimenopause Changes the Rules — and How to Feel Like Yourself Through It
Most of what's written about GLP-1 medications treats every body as the same body. But a woman navigating perimenopause is not working with the same physiology she had at 25 — and when it comes to these medications, that difference matters more than almost anyone is telling her. If you're in your forties or fifties and either curious about a GLP-1, considering one, or already taking one, the rules shift in your favour once you understand them.
This isn't a reason to avoid GLP-1 in midlife. It's a reason to support your body more deliberately while you're on it — because two big changes are happening at once, and they pull in the same direction.
The Collision Nobody Warns You About
Here's the part that gets missed. From perimenopause onwards, falling oestrogen already nudges your body to lose muscle — a process called sarcopenia that accelerates around menopause. Oestrogen helps you build and hold lean tissue, so as it declines, muscle becomes harder to keep and easier to lose.
Now add a GLP-1. Rapid weight loss never takes only fat — in the STEP 1 trial, a meaningful share of the weight lost was lean tissue. So a midlife woman on a GLP-1 faces a double subtraction: the medication trims muscle at the same time her hormones are already trimming it. It's a squeeze that a woman in her twenties simply doesn't face — and it's exactly why the standard advice needs a midlife rewrite.
Why Midlife Metabolism Amplifies Everything
The menopausal transition also changes how your body handles energy. In a well-known study tracking women through menopause, becoming postmenopausal was linked to a significant rise in visceral fat (the deep abdominal kind), an eight percent drop in energy expenditure at rest, and a striking thirty-two percent fall in fat oxidation — the rate at which the body burns fat for fuel.
In plain terms: weight starts to settle around the middle, and your body burns a little less, all on its own. This is why so many women feel their old approach to weight suddenly stops working in midlife. A GLP-1 can genuinely help here — but it's working against a stronger metabolic tide than it would in a younger body, which makes what you do alongside it matter even more.
The Symptoms That Stack
There's an overlap most women feel but few connect. Perimenopause brings fatigue, brain fog, disrupted sleep and sluggish digestion. The early weeks of a low-appetite GLP-1 phase can bring almost exactly the same list. When they land together, they don't just add up — they amplify, and it's easy to feel far more depleted than you expected. Naming it helps: much of what feels like "something's wrong with me" is really two normal physiological shifts overlapping, and both respond to the same kind of support.
Protein Stops Being Optional
Here's the cruel irony of midlife weight loss: your protein needs go up exactly as your appetite goes down. Older women appear to do better on more protein than the standard guideline — a review of protein in post-menopausal women points to intakes above the basic 0.8 g/kg recommendation, closer to 1.0–1.2 g/kg a day, to help protect muscle, especially when paired with strength work. On a GLP-1, when a full meal can feel like too much, hitting that target from food alone is genuinely hard. This is precisely where a quality protein supplement earns its place — a gentle, reliable way to top up on the days your appetite is small but your muscle still needs feeding.
Move to Protect Muscle — and Bone
The single most powerful thing a midlife woman can do on a GLP-1 is resistance training. It's the strongest signal you can send your body to hold on to muscle, and it directly counters the oestrogen-related muscle loss of menopause. You don't need hours in a gym — a couple of short strength sessions a week is enough to change the trajectory.
Bone deserves a special mention here, because it's the one thing truly unique to this age group. Falling oestrogen already thins bone, and there's growing concern that rapid GLP-1 weight loss can compound it — clinicians have described the combination as a "perfect storm" for bone loss in midlife women. Weight-bearing and resistance exercise, enough protein, and adequate vitamin D and calcium all help protect the skeleton while you lose the fat. It's one more reason the midlife approach is about building strength, not just shrinking.
Support Your Digestion and Energy
Both the medication and lower oestrogen can slow digestion, so constipation is common — and uncomfortable. Fibre and fluids are your allies, with a lovely bonus: when gut bacteria ferment fibre, they produce short-chain fatty acids that stimulate your body's own GLP-1 — so fibre eases the side effect and gently supports the hormone at the same time. And for the fog and flatness that midlife and a small appetite can bring, prioritising nutrient-dense food, hydration and the right building blocks for focus, energy and strength helps you feel like yourself while your body recalibrates.
So — Can You Do This in Midlife? Absolutely.
None of this is a warning to stay away. GLP-1 medications can be genuinely helpful for midlife women — the point is simply that your body asks for more deliberate support than the generic advice assumes. Protect your muscle, protect your bone, keep protein high, move with resistance, look after your gut, and have an honest conversation with your healthcare provider about your options, including whether hormone support has a place in your bigger picture. Do that, and you're working with your midlife physiology instead of against it.
In Summary — GLP-1 in Perimenopause
- 🌿 Falling oestrogen already drives muscle loss; a GLP-1 can add to it — midlife women face a double hit that younger women don't.
- 🌿 Menopause shifts fat to the middle and slows your burn, so what you do alongside the medication matters even more.
- 🌿 Protein needs rise as appetite falls — aim higher (around 1.0–1.2 g/kg), and top up when meals feel like too much.
- 🌿 Resistance training protects muscle and bone — the one thing most worth doing while the fat comes off.
- 🌿 Support digestion with fibre (which feeds your own GLP-1), and look after focus and energy through the overlap of symptoms.
Supporting Your Body Through GLP-1 in Midlife
At LoveSelf, we believe midlife deserves support built for it — which is exactly why our GLP-1 Support Pack works so well for this stage. It brings together three daily essentials for a woman navigating a GLP-1 through perimenopause and beyond: Protein Power to help protect the lean muscle your hormones are no longer defending, Tummy Tamer to support digestion and feed your body's own GLP-1 through fibre, and Mind & Muscle to support the focus, energy and strength that midlife and a small appetite can drain. Whether you're on a GLP-1 or simply supporting your body's own, it's a simple way to feel nourished, steady and strong.
Explore the LoveSelf GLP-1 Support Pack →
Start within. Feel the difference.
This article is for educational purposes and is not medical advice. GLP-1 medications are prescription-only and should be started, adjusted or stopped only under the guidance of a qualified healthcare professional. Supplements are intended to support, not replace, a balanced diet. Always consult your healthcare provider for personalised advice, particularly if you are pregnant, breastfeeding, managing a health condition, or considering hormone therapy.
References
- Changes in muscle mass and strength after menopause. Journal of Musculoskeletal & Neuronal Interactions, 2009. Read the study
- Lovejoy JC, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity, 2008. Read the study
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021. Read the study
- Role of exercise in estrogen deficiency-induced sarcopenia (review), 2022. Read the review
- Protein intake and muscle mass and strength in post-menopausal women: a narrative review. Journal of Ageing and Longevity, 2024. Read the review
- Neeland IJ, et al. Changes in lean body mass with GLP-1-based therapies and mitigation strategies. Diabetes, Obesity & Metabolism, 2024. Read the study
- Menopause and GLP-1 weight-loss drugs: a 'perfect storm' for bone loss. UCHealth, 2024. Read the article
- Tolhurst G, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via FFAR2. Diabetes, 2012. Read the study



